was read the article
array:22 [ "pii" => "S2173574323000217" "issn" => "21735743" "doi" => "10.1016/j.reumae.2022.09.001" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "1647" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2023;19:174" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemAnterior" => array:18 [ "pii" => "S2173574323000205" "issn" => "21735743" "doi" => "10.1016/j.reumae.2022.10.001" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "1656" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2023;19:173" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Reply to the Letter to the Editor from Drs Suárez-Diaz and Caminal-Montero in reference to the special article “Recommendations for prevention of infection in systemic autoimmune rheumatic diseases”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "173" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "En respuesta a la Carta al Editor de los Dres. Suárez-Diaz y Caminal-Montero en referencia al artículo especial «Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Íñigo Rúa-Figueroa Fernández de Larrinoa, Patricia Carreira Delgado, Noé Brito García, Beatriz Tejera Segura, Julián de la Torre Cisneros" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Íñigo" "apellidos" => "Rúa-Figueroa Fernández de Larrinoa" ] 1 => array:2 [ "nombre" => "Patricia" "apellidos" => "Carreira Delgado" ] 2 => array:2 [ "nombre" => "Noé" "apellidos" => "Brito García" ] 3 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Tejera Segura" ] 4 => array:2 [ "nombre" => "Julián" "apellidos" => "de la Torre Cisneros" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574323000205?idApp=UINPBA00004M" "url" => "/21735743/0000001900000003/v1_202303101257/S2173574323000205/v1_202303101257/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments: Recommendations for prevention of infection in systemic autoimmunerheumatic diseases" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "174" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Silvia Suárez-Díaz, Luis Caminal-Montero" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Silvia" "apellidos" => "Suárez-Díaz" "email" => array:1 [ 0 => "silvia_porto@hotmail.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Luis" "apellidos" => "Caminal-Montero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Valle del Nalón, Langreo, Asturias, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Medicina Interna, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentario a: Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read with interest the excellent systematic review by Rúa-Figueroa Fernández de Larrinoa et al., representing SER experts and published in Reumatología Clínica<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> on the prevention of infections in systemic autoimmune rheumatic diseases. We would like to make a few remarks in connection with these general recommendations.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Prophylaxis is recommended with trimethoprim/sulfa metoxazole (TMP/SMX) at a dose of 400/80<span class="elsevierStyleHsp" style=""></span>mg per day against <span class="elsevierStyleItalic">Pneumocystis jirovecii</span> in patients with systemic autoimmune rheumatic diseases treated continuously with doses of glucocorticoids ≥20<span class="elsevierStyleHsp" style=""></span>mg/day. These recommendations may lead to error, given that the tablets commercialized in Spain under the name Septrin® contain 80<span class="elsevierStyleHsp" style=""></span>mg TMP and 400<span class="elsevierStyleHsp" style=""></span>mg SMX, while Septrin Forte® are twice this dose: TMP 160/SMX 800.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">On the other hand, we consider that it may be of interest to include recommendations in case of latent tuberculous infection outside treatments with anti-TNF.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This subject was recently raised in other journals in a general sense,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> where the specific advice was to routinely apply the IGRA test for all patients received glucocorticoids at an equivalent dose to prednisone 2<span class="elsevierStyleHsp" style=""></span>mg/kg/day, 15<span class="elsevierStyleHsp" style=""></span>mg per day during at least one month, or other immunosuppressant medication. Nevertheless, when indicating prophylactic treatment for a latent tuberculous infection recommendations are less strict. They propose indicating treatment only after a risk/benefit analysis and evaluation of possible interactions and the risk of hepatotoxicity, without considering the specific risk of the different synthetic or biological immunosuppressant drugs or reviewing the evidence for this.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interests</span><p id="par0020" class="elsevierStylePara elsevierViewall">The authors have no conflict of interests to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interests" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recommendations for prevention of infection in systemic autoimmune rheumatic diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Í Rúa-Figueroa Fernández de Larrinoa" 1 => "P.E. Carreira" 2 => "N. Brito García" 3 => "P. Díaz Del Campo Fontecha" 4 => "J.M. Pego Reigosa" 5 => "J.A. Gómez Puerta" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin (Engl Ed)" "fecha" => "2021" "volumen" => "S1699-258X" "numero" => "21" "paginaInicial" => "00124" "paginaFinal" => "00128" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Agencia Española de Medicamentos y Productos Sanitarios. Ficha técnica Septrin. (Consultado el 15 de Agosto de 2022.). Available from: <a target="_blank" href="https://cima.aemps.es/cima/pdfs/es/ft/58501/FT_58501.pdf">https://cima.aemps.es/cima/pdfs/es/ft/58501/FT_58501.pdf</a>." ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consensus document on prevention and treatment of tuberculosis in patients for biological treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Mir Viladrich" 1 => "E. Daudén Tello" 2 => "G. Solano-López" 3 => "F.J. López Longo" 4 => "C. Taxonera Samso" 5 => "P. Sánchez Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2015.04.016" "Revista" => array:7 [ "tituloSerie" => "Arch Bronconeumol." "fecha" => "2016" "volumen" => "52" "numero" => "1" "paginaInicial" => "36" "paginaFinal" => "45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26187708" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Latent tuberculosis infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Shah" 1 => "S.E. Dorman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMcp2108501" "Revista" => array:7 [ "tituloSerie" => "N Engl J Med." "fecha" => "2021" "volumen" => "385" "numero" => "24" "paginaInicial" => "2271" "paginaFinal" => "2280" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34879450" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001900000003/v1_202303101257/S2173574323000217/v1_202303101257/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001900000003/v1_202303101257/S2173574323000217/v1_202303101257/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574323000217?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 11 | 17 | 28 |
2024 October | 31 | 28 | 59 |
2024 September | 33 | 19 | 52 |
2024 August | 42 | 38 | 80 |
2024 July | 47 | 35 | 82 |
2024 June | 39 | 41 | 80 |
2024 May | 31 | 28 | 59 |
2024 April | 36 | 20 | 56 |
2024 March | 38 | 24 | 62 |
2024 February | 23 | 21 | 44 |
2024 January | 20 | 15 | 35 |
2023 December | 17 | 24 | 41 |
2023 November | 40 | 35 | 75 |
2023 October | 28 | 23 | 51 |
2023 September | 55 | 40 | 95 |
2023 July | 2 | 1 | 3 |
2023 April | 1 | 0 | 1 |
2023 March | 12 | 11 | 23 |